FDA approves Guardant Health's expanded liquid biopsy test

May 20, 2026 8:05 AM

The U.S. Food and Drug Administration has approved Guardant Health Inc.'s (NASDAQ: GH) Guardant360 Liquid CDx, a blood-based cancer testing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found